Atlas Trials

Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis

Clinical trial NCT01864018 · COMPLETED

Trial details

NCT number
NCT01864018
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
AmyloidosisPlasma Cell Myeloma
Start date
2013-08-20
Primary completion
2021-04-30
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.